📰 Nasdaq Sls News
Nasdaq Sls News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Sls. Real-time updates on events, politics, business and more.
February 13, 2024
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS – Get Free Report) was the recipient of a large decrease in short interest in January. As of January 31st, there was short interest totalling 3,120,000 shares, a decrease of 19.6% from the January 15th total of 3,880,000 shares. Based on an average daily trading volume, of 990,800 shares, […]
January 4, 2024
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical...
December 14, 2023
SELLAS Life Sciences Group (NASDAQ:SLS – Get Free Report) and Imunon (NASDAQ:IMNN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations. Risk and Volatility SELLAS Life Sciences […]
November 16, 2023
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS – Free Report) – Investment analysts at Cantor Fitzgerald lowered their FY2023 earnings per share estimates for SELLAS Life Sciences Group in a research report issued to clients and investors on Monday, November 13th. Cantor Fitzgerald analyst L. Watsek now forecasts that the company will post earnings of ($1.04) […]
November 13, 2023
The stock of SELLAS Life Sciences Group Inc (NASDAQ: SLS) has decreased by -2.70 when compared to last closing price of 0.91.Despite this, the company has seen a loss of -8.53% in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-17 that NEW YORK, Oct. 17, 2023 (GLOBE N
November 6, 2023
Median overall survival for GPS and Keytruda® combination was 18.4 Months compared to 13.8 Months in a Keytruda® single agent study (KEYNOTE-028) and 11-14...
November 6, 2023
The stock of SELLAS Life Sciences Group Inc (NASDAQ: SLS) has increased by 1.23 when compared to last closing price of 0.96. Despite this, the company has experienced a -16.22% fall in its stock price over the last five trading sessions. GlobeNewsWire reported 2023-10-17 that NEW YORK, Oct. 17, 2023
October 31, 2023
The stock of SELLAS Life Sciences Group Inc (NASDAQ: SLS) has increased by 23.98 when compared to last closing price of 0.94.Despite this, the company has seen a gain of 29.18% in its stock price over the last five trading days. GlobeNewsWire reported 2023-10-17 that NEW YORK, Oct. 17, 2023 (GLOBE N
October 30, 2023
- SLS009 Demonstrated Promising Efficacy in Phase 1 Study with 36.4% Clinical Response (ORR) in r/r Peripheral T-cell Lymphomas (PTCL); ORR in r/r PTCL...
October 26, 2023
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS – Get Free Report) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totalling 2,040,000 shares, a growth of 87.2% from the September 30th total of 1,090,000 shares. Based on an average trading volume of 314,700 shares, the […]